Cargando…

Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample

BACKGROUND: While ovarian cancer is recognised as having identifiable early symptoms, understanding of the key determinants of symptom awareness and early presentation is limited. A population-based survey of ovarian cancer awareness and anticipated delayed presentation with symptoms was conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brain, Kate E, Smits, Stephanie, Simon, Alice E, Forbes, Lindsay J, Roberts, Chris, Robbé, Iain J, Steward, John, White, Ceri, Neal, Richard D, Hanson, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975332/
https://www.ncbi.nlm.nih.gov/pubmed/24612526
http://dx.doi.org/10.1186/1471-2407-14-171
_version_ 1782310129061855232
author Brain, Kate E
Smits, Stephanie
Simon, Alice E
Forbes, Lindsay J
Roberts, Chris
Robbé, Iain J
Steward, John
White, Ceri
Neal, Richard D
Hanson, Jane
author_facet Brain, Kate E
Smits, Stephanie
Simon, Alice E
Forbes, Lindsay J
Roberts, Chris
Robbé, Iain J
Steward, John
White, Ceri
Neal, Richard D
Hanson, Jane
author_sort Brain, Kate E
collection PubMed
description BACKGROUND: While ovarian cancer is recognised as having identifiable early symptoms, understanding of the key determinants of symptom awareness and early presentation is limited. A population-based survey of ovarian cancer awareness and anticipated delayed presentation with symptoms was conducted as part of the International Cancer Benchmarking Partnership (ICBP). METHODS: Women aged over 50 years were recruited using random probability sampling (n = 1043). Computer-assisted telephone interviews were used to administer measures including ovarian cancer symptom recognition, anticipated time to presentation with ovarian symptoms, health beliefs (perceived risk, perceived benefits/barriers to early presentation, confidence in symptom detection, ovarian cancer worry), and demographic variables. Logistic regression analysis was used to identify the contribution of independent variables to anticipated presentation (categorised as < 3 weeks or ≥ 3 weeks). RESULTS: The most well-recognised symptoms of ovarian cancer were post-menopausal bleeding (87.4%), and persistent pelvic (79.0%) and abdominal (85.0%) pain. Symptoms associated with eating difficulties and changes in bladder/bowel habits were recognised by less than half the sample. Lower symptom awareness was significantly associated with older age (p ≤ 0.001), being single (p ≤ 0.001), lower education (p ≤ 0.01), and lack of personal experience of ovarian cancer (p ≤ 0.01). The odds of anticipating a delay in time to presentation of ≥ 3 weeks were significantly increased in women educated to degree level (OR = 2.64, 95% CI 1.61 – 4.33, p ≤ 0.001), women who reported more practical barriers (OR = 1.60, 95% CI 1.34 – 1.91, p ≤ 0.001) and more emotional barriers (OR = 1.21, 95% CI 1.06 – 1.40, p ≤ 0.01), and those less confident in symptom detection (OR = 0.56, 95% CI 0.42 – 0.73, p ≤ 0.001), but not in those who reported lower symptom awareness (OR = 0.99, 95% CI 0.91 – 1.07, p = 0.74). CONCLUSIONS: Many symptoms of ovarian cancer are not well-recognised by women in the general population. Evidence-based interventions are needed not only to improve public awareness but also to overcome the barriers to recognising and acting on ovarian symptoms, if delays in presentation are to be minimised.
format Online
Article
Text
id pubmed-3975332
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39753322014-04-05 Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample Brain, Kate E Smits, Stephanie Simon, Alice E Forbes, Lindsay J Roberts, Chris Robbé, Iain J Steward, John White, Ceri Neal, Richard D Hanson, Jane BMC Cancer Research Article BACKGROUND: While ovarian cancer is recognised as having identifiable early symptoms, understanding of the key determinants of symptom awareness and early presentation is limited. A population-based survey of ovarian cancer awareness and anticipated delayed presentation with symptoms was conducted as part of the International Cancer Benchmarking Partnership (ICBP). METHODS: Women aged over 50 years were recruited using random probability sampling (n = 1043). Computer-assisted telephone interviews were used to administer measures including ovarian cancer symptom recognition, anticipated time to presentation with ovarian symptoms, health beliefs (perceived risk, perceived benefits/barriers to early presentation, confidence in symptom detection, ovarian cancer worry), and demographic variables. Logistic regression analysis was used to identify the contribution of independent variables to anticipated presentation (categorised as < 3 weeks or ≥ 3 weeks). RESULTS: The most well-recognised symptoms of ovarian cancer were post-menopausal bleeding (87.4%), and persistent pelvic (79.0%) and abdominal (85.0%) pain. Symptoms associated with eating difficulties and changes in bladder/bowel habits were recognised by less than half the sample. Lower symptom awareness was significantly associated with older age (p ≤ 0.001), being single (p ≤ 0.001), lower education (p ≤ 0.01), and lack of personal experience of ovarian cancer (p ≤ 0.01). The odds of anticipating a delay in time to presentation of ≥ 3 weeks were significantly increased in women educated to degree level (OR = 2.64, 95% CI 1.61 – 4.33, p ≤ 0.001), women who reported more practical barriers (OR = 1.60, 95% CI 1.34 – 1.91, p ≤ 0.001) and more emotional barriers (OR = 1.21, 95% CI 1.06 – 1.40, p ≤ 0.01), and those less confident in symptom detection (OR = 0.56, 95% CI 0.42 – 0.73, p ≤ 0.001), but not in those who reported lower symptom awareness (OR = 0.99, 95% CI 0.91 – 1.07, p = 0.74). CONCLUSIONS: Many symptoms of ovarian cancer are not well-recognised by women in the general population. Evidence-based interventions are needed not only to improve public awareness but also to overcome the barriers to recognising and acting on ovarian symptoms, if delays in presentation are to be minimised. BioMed Central 2014-03-10 /pmc/articles/PMC3975332/ /pubmed/24612526 http://dx.doi.org/10.1186/1471-2407-14-171 Text en Copyright © 2014 Brain et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Brain, Kate E
Smits, Stephanie
Simon, Alice E
Forbes, Lindsay J
Roberts, Chris
Robbé, Iain J
Steward, John
White, Ceri
Neal, Richard D
Hanson, Jane
Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
title Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
title_full Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
title_fullStr Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
title_full_unstemmed Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
title_short Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
title_sort ovarian cancer symptom awareness and anticipated delayed presentation in a population sample
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975332/
https://www.ncbi.nlm.nih.gov/pubmed/24612526
http://dx.doi.org/10.1186/1471-2407-14-171
work_keys_str_mv AT brainkatee ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT smitsstephanie ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT simonalicee ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT forbeslindsayj ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT robertschris ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT robbeiainj ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT stewardjohn ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT whiteceri ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT nealrichardd ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample
AT hansonjane ovariancancersymptomawarenessandanticipateddelayedpresentationinapopulationsample